Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2015

Mar 3, 2015

31971_dirs_2015-03-03_8b5019fe-0d6e-4c01-92b3-c6fa3e2f5c19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-02-27

Reporting Person: Hartman Curt R (President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-27 Rsus (restricted Stock Units) $0 A 7800 Acquired 2025-02-27 Common Stock (7800) Direct
2015-02-27 Sars (Stock Appreciation Rights) $51.30 A 148300 Acquired 2025-02-27 Common Stock (148300) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period.